Bortezomib Intravenous and Daunorubicin Intravenous

• Generic Name: bortezomib
• Dosage Forms: n.a.
• Other Brand Names: Velcade

Bortezomib injection is used to treat multiple myeloma (blood plasma cell cancer) in patients with or without a prior history of treatment, and mantle cell lymphoma.

Bortezomib is an antineoplastic agent (cancer medicine). It interferes with the growth of cancer cells, which are eventually destroyed by the body. Since the growth of normal body cells may also be affected by bortezomib, other effects will also occur. Some of these may be serious and must be reported to your doctor. Other effects, such as a skin rash, may not be serious but may cause concern. Some effects may not occur until months or years after the medicine is used.

Bortezomib is to be given only by or under the supervision of your doctor.

• Generic Name: daunorubicin
• Dosage Forms: n.a.
• Other Brand Names: Cerubidine

Daunorubicin belongs to the general group of medicines known as antineoplastics. It is used to treat some kinds of cancer.

Daunorubicin seems to interfere with the growth of cancer cells, which are eventually destroyed. Since the growth of normal body cells may also be affected by daunorubicin, other effects will also occur. Some of these may be serious and must be reported to your doctor. Other effects, like hair loss, may not be serious but may cause concern. Some effects may not occur for months or years after the medicine is used.

Before you begin treatment with daunorubicin, you and your doctor should talk about the good daunorubicin will do as well as the risks of using it.

Daunorubicin is to be administered only by or under the immediate supervision of your doctor.